Achieve Life Sciences

Forecast & Rating13 analysts currently cover Achieve Life Sciences, with about 92.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $14.15, about 118.1% upside from the current price of $6.49. Price targets range from $9.00 to $21.00 — a wide spread, showing clear disagreement over just how much Achieve Life Sciences can rise. For you, this means most professionals who study Achieve Life Sciences closely still see room for the stock to rise. Data as of Oct 21, 2026; for reference only and not investment advice.